Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Syngene International

Sector: Healthcare | Industry: Drugs & Pharma
R 330.95 4.20  | 1.29% 13.47% 39.15 13,210.00
NSE Price: Oct 23, 15:55 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23, 15:55 330.95 4.20 1.29% 333.95 326.75 221,850 330.00 - 344.35
BSE Oct 23, 2019 330.25 3.80 1.16% 333.60 326.45 12,380 330.00 - 342.45
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue1,886.501,825.601,423.10-- --
Other Income84.4076.20136.10-- --
Total Income1,970.901,901.801,559.20-- --
Total Expenditure1,330.801,289.901,032.60-- --
Operating Profit640.10611.90526.60-- --
Interest31.7032.3022.70-- --
PBDT608.40579.60503.90-- --
Depreciation187.00164.20131.40-- --
PBT & Exceptional Items421.40415.40372.50-- --
Exceptional Items71.30---- --
Profit before Tax492.70415.40372.50-- --
Provision for Tax105.5083.8067.10-- --
Profit after Tax387.20331.60305.40-- --
Minority Interest0.00---- --
Share of Associate0.00---- --
Consolidated Profit387.20331.60305.40-- --
 
LiabilitiesR Cr
Share Capital400.00200.00200.00-- --
Total Reserves1,690.201,740.401,492.20-- --
Shareholder's Funds2,090.201,968.401,720.40-- --
Minority Interest----- --
Long Term Borrowings353.20361.70585.50-- --
Other Non Current Liabilities361.30244.8099.50-- --
Current Liabilities1,150.901,128.60783.60-- --
Total Debt*-813.30787.40-- --
Total Liabilities3,955.603,703.503,189.00-- --
 
AssetsR Cr
Net Block1,614.701,336.801,030.40-- --
Non Current Investments325.0040.00--- --
Other Non-Current Assets650.30562.60438.40-- --
Current Investments541.00716.00157.70-- --
Cash and Bank235.90436.90967.40-- --
Other Current Assets588.70611.20595.10-- --
Net Current Assets214.70635.50936.60-- --
Miscellaneous Exp. Not Written Off----- --
Total Assets3,955.603,703.503,189.00-- --
 
Cash FlowR Cr
From Operations-630.40446.20-- --
From Investing Activities--646.50-349.30-- --
From Finance Activities--72.40-78.70-- --
Net Inflow/Outflow--88.5018.20-- --
 
Key Ratios
Adjusted EPS (Rs)8.448.297.64-- --
Adjusted Book Value (Rs)55.3148.5142.31-- --
Dividend per Share (Rs)-0.501.00-- --
Cash Flow per Share (Rs)-31.5222.31-- --
Debt to Equity0.170.420.47-- --
Current Ratio1.191.562.20-- --
ROCE (%)-16.9315.76-- --
RONW (%)21.0918.2618.05-- --
Operating Margin (%)33.9333.5237.00-- --
Net Margin (%)19.6517.4419.59-- --
Revenue Growth (%)16.3528.280.00-- --
Net Profit Growth (%)24.508.580.00-- --
EPS Growth (%)24.508.580.00-- --
Book Value Growth (%)-14.670.00-- --
 
Market Cues
Close Price (Rs)330.95297.65298.60-- --
High Price (Rs)369.00350.00336.00-- --
Low Price (Rs)250.05250.05215.05-- --
Market Cap (Rs Cr)13,210.0011,759.0011,776.00-- --
Price / Earnings39.1535.4638.56-- --
Price / Book Value5.976.066.96-- --
Dividend Yield (%)0.080.090.17-- --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
6.41
Piotroski F-Score
7
Modified C-Score
0
1-Year Price to Earnings
39.15
1-Year Price to Book
5.97
Earnings Yield
EBIT / Enterprise value
4.07%
PEG
Price / Earnings to growth ratio
0.31
Related Stocks
  Current Price   Chng %
Abbott India R10,914.25 +2.00%
Alkem Laboratories R1,966.85 -0.40%
Biocon R258.30 +0.53%
Cadila Healthcare R247.85 +1.06%
Cipla R454.25 +0.08%
Glaxosmithkline Pharma R1,488.55 +0.50%
Lupin R736.15 -1.30%
Pfizer R3,270.65 +0.32%
Piramal Enterprises R1,720.75 +2.40%
Torrent Pharmaceuticals R1,680.25 +0.61%
As on Oct 23, 15:59